Wang Huaijun, Felt Stephen A, Machtaler Steven, Guracar Ismayil, Luong Richard, Bettinger Thierry, Tian Lu, Lutz Amelie M, Willmann Jürgen K
From the Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, 300 Pasteur Dr, Room H1307; Stanford, CA 94305-5621 (H.W., S.M., A.M.L., J.K.W.); Department of Comparative Medicine (S.A.F., R.L.) and Department of Health, Research and Policy (L.T.), Stanford University, Stanford, Calif; Ultrasound Business Unit, Siemens Healthcare, Mountain View, Calif (I.G.); and Bracco Suisse, Geneva, Switzerland (T.B.).
Radiology. 2015 Sep;276(3):809-17. doi: 10.1148/radiol.2015142478. Epub 2015 May 12.
To evaluate the feasibility and reproducibility of ultrasonography (US) performed with dual-selectin-targeted contrast agent microbubbles (MBs) for assessment of inflammation in a porcine acute terminal ileitis model, with histologic findings as a reference standard.
The study had institutional Animal Care and Use Committee approval. Acute terminal ileitis was established in 19 pigs; four pigs served as control pigs. The ileum was imaged with clinical-grade dual P- and E-selectin-targeted MBs (MBSelectin) at increasing doses (0.5, 1.0, 2.5, 5.0, 10, and 20 × 10(8) MB per kilogram of body weight) and with control nontargeted MBs (MBControl). For reproducibility testing, examinations were repeated twice after the MBSelectin and MBControl injections. After imaging, scanned ileal segments were analyzed ex vivo both for inflammation grade (by using hematoxylin-eosin staining) and for expression of selectins (by using quantitative immunofluorescence analysis). Statistical analysis was performed by using the t test, intraclass correlation coefficients (ICCs), and Spearman correlation analysis.
Imaging signal increased linearly (P < .001) between a dose of 0.5 and a dose of 5.0 × 10(8) MB/kg and plateaued between a dose of 10 and a dose of 20 × 10(8) MB/kg. Imaging signals were reproducible (ICC = 0.70), and administration of MBSelectin in acute ileitis resulted in a significantly higher (P < .001) imaging signal compared with that in control ileum and MBControl. Ex vivo histologic grades of inflammation correlated well with in vivo US signal (ρ = 0.79), and expression levels of both P-selectin (37.4% ± 14.7 [standard deviation] of vessels positive; P < .001) and E-selectin (31.2% ± 25.7) in vessels in the bowel wall of segments with ileitis were higher than in control ileum (5.1% ± 3.7 for P-selectin and 4.8% ± 2.3 for E-selectin).
Quantitative measurements of inflammation obtained by using dual-selectin-targeted US are reproducible and correlate well with the extent of inflammation at histologic examination in a porcine acute ileitis model as a next step toward clinical translation.
以组织学检查结果作为参考标准,评估使用双选择素靶向造影剂微泡(MBs)进行超声检查(US)在猪急性末端回肠炎模型中评估炎症的可行性和可重复性。
本研究获得机构动物护理和使用委员会的批准。19头猪建立急性末端回肠炎模型;4头猪作为对照猪。使用临床级双P-和E-选择素靶向微泡(MBSelectin)以递增剂量(每千克体重0.5、1.0、2.5、5.0、10和20×10⁸个MB)以及对照非靶向微泡(MBControl)对回肠进行成像。为进行可重复性测试,在注射MBSelectin和MBControl后检查重复两次。成像后,对扫描的回肠段进行离体分析,评估炎症分级(使用苏木精-伊红染色)和选择素表达(使用定量免疫荧光分析)。采用t检验、组内相关系数(ICC)和Spearman相关分析进行统计分析。
在剂量为0.5×10⁸至5.0×10⁸个MB/kg之间成像信号呈线性增加(P <.001),在剂量为10×10⁸至20×10⁸个MB/kg之间达到平台期。成像信号具有可重复性(ICC = 0.70),与对照回肠和MBControl相比,急性回肠炎中注射MBSelectin导致成像信号显著更高(P <.001)。离体组织学炎症分级与体内超声信号相关性良好(ρ = 0.79),回肠炎段肠壁血管中P-选择素(阳性血管的37.4%±14.7[标准差];P <.001)和E-选择素(31.2%±25.7)的表达水平均高于对照回肠(P-选择素为5.1%±3.7,E-选择素为4.8%±2.3)。
在猪急性回肠炎模型中,使用双选择素靶向超声获得的炎症定量测量结果具有可重复性,并且与组织学检查中的炎症程度相关性良好,这是迈向临床转化的下一步。